Hypoxia Inducible Factor-1α Directly Induces the Expression of Receptor Activator of Nuclear Factor-κB Ligand in Chondrocytes
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Receptor activator of nuclear factor-κB ligand (RANKL) is an osteoblast/stromal cell-derived essential factor for osteoclastogenesis. During endochondral bone formation, hypertrophic chondrocytes calcify cartilage matrix that is subsequently resorbed by osteoclasts in order to be replaced by new bone. Hypoxia-induced upregulation of RANKL expression has been previously demonstrated in an in vitro system using osteoblasts; however, the involved mechanism remains unclear in chondrocytes. In the present study, we investigated whether hypoxia regulates RANKL expression in ATDC5 cells, a murine chondrogenic cell line, and hypoxiainducible factor-1α (HIF-1α) mediates hypoxia-induced RANKL expression by transactivating the RANKL promoter. The expression levels of RANKL mRNA and protein, as well as HIF-1α protein, were significantly increased in ATDC5 cells under hypoxic condition. Constitutively active HIF-1α alone significantly increased the levels of RANKL expression under normoxic conditions, whereas dominant negative HIF-1α reduced hypoxia-induced RANKL expression. HIF-1α increased RANKL promoter reporter activity in a HIF-1α binding element-dependent manner in ATDC5 cells. Hypoxia-induced RANKL levels were much higher in differentiated ATDC5 cells, as compared to proliferating ATDC5 cells. These results suggested that under hypoxic conditions, HIF-1α mediates induction of RANKL expression in chondrocytes; in addition, hypoxia plays a role in osteoclastogenesis during endochondral bone formation, at least in part, through the induction of RANKL expression in hypertrophic chondrocytes.
Abstract
Receptor activator of nuclear factor-κB ligand (RANKL) is an osteoblast/stromal cell-derived essential factor for osteoclastogenesis. During endochondral bone formation, hypertrophic chondrocytes calcify cartilage matrix that is subsequently resorbed by osteoclasts in order to be replaced by new bone. Hypoxia-induced upregulation of RANKL expression has been previously demonstrated in an in vitro system using osteoblasts; however, the involved mechanism remains unclear in chondrocytes. In the present study, we investigated whether hypoxia regulates RANKL expression in ATDC5 cells, a murine chondrogenic cell line, and hypoxiainducible factor-1α (HIF-1α) mediates hypoxia-induced RANKL expression by transactivating the RANKL promoter. The expression levels of RANKL mRNA and protein, as well as HIF-1α protein, were significantly increased in ATDC5 cells under hypoxic condition. Constitutively active HIF-1α alone significantly increased the levels of RANKL expression under normoxic conditions, whereas dominant negative HIF-1α reduced hypoxia-induced RANKL expression. HIF-1α increased RANKL promoter reporter activity in a HIF-1α binding element-dependent manner in ATDC5 cells. Hypoxia-induced RANKL levels were much higher in differentiated ATDC5 cells, as compared to proliferating ATDC5 cells. These results suggested that under hypoxic conditions, HIF-1α mediates induction of RANKL expression in chondrocytes; in addition, hypoxia plays a role in osteoclastogenesis during endochondral bone formation, at least in part, through the induction of RANKL expression in hypertrophic chondrocytes.
참고문헌 (32)
- B. C. J. van der Eerden, "Systemic and Local Regulation of the Growth Plate", Endocrine Reviews, 24(6), pp.782~801 (2003), The Endocrine Society[DOI]
- Michihiko Usui, "Murine and Chicken Chondrocytes Regulate Osteoclastogenesis by Producing RANKL in Response to BMP2", Journal of Bone and Mineral Research, 23(3), pp.314~325 (2008), Wiley-Blackwell[DOI]
- Hisahiro Yoshida, "The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene", Nature, 345(6274), pp.442~444 (1990), Springer Nature[DOI]
- Kenichiro Matsuzaki, "Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures", Biochemical and Biophysical Research Communications, 246(1), pp.199~204 (1998), Elsevier BV[DOI]
- D.L Lacey, "Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation", Cell, 93(2), pp.165~176 (1998), Elsevier BV[DOI]
- Ellen M. Gravallese, "Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor", Arthritis & Rheumatism, 43(2), pp.250~ (2000), Wiley-Blackwell[DOI]
- Josef M. Penninger, "Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand", Nature, 402(6759), pp.304~309 (1999), Springer Nature[DOI]
- Shinichi Shimizu, "Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis", Arthritis & Rheumatism, 28(1), pp.25~31 (1985), Wiley-Blackwell[DOI]
- Y. Li, "B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo", Blood, 109(9), pp.3839~3848 (2007), American Society of Hematology[DOI]
- Kenta Kishimoto, "Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage", Histochemistry and Cell Biology, 125(5), pp.593~602 (2006), Springer Nature[DOI]
- Ritsuko Masuyama, "Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts", Journal of Clinical Investigation, 116(12), pp.3150~3159 (2006), American Society for Clinical Investigation[DOI]
- E. SCHIPANI, "Hypoxia and HIF-1 in Chondrogenesis", Annals of the New York Academy of Sciences, 1068(1), pp.66~73 (2006), Wiley-Blackwell[DOI]
- Dodd JS, "Osteocyte hypoxia: a novel mechanotransduction pathway", Am J Physiol, 277, pp.C598~C602 (1999)
- Devakara R. Epari, "Pressure, oxygen tension and temperature in the periosteal callus during bone healing—An in vivo study in sheep", Bone, 43(4), pp.734~739 (2008), Elsevier BV[DOI]
- H Najafipour, "Comparison of synovial PO2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints", Experimental Physiology, 80(2), pp.209~220 (1995), Wiley-Blackwell[DOI]
- Kiaer T, "Subchondral pO2, pCO2, pressure, pH, and lactate in human osteoarthritis of the hip", Clin Orthop Relat Res, 229, pp.149~155 (1988)
- Agnieszka Loboda, "HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical", Molecules and Cells, 29(5), pp.435~442 (2010), 한국분자세포생물학회
- H. J. Knowles, "Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4", The FASEB Journal, 24(12), pp.4648~4659 (2010), FASEB[DOI]
- Hyun-Jung Park, "Hypoxia Inducible Factor-1α Directly Induces then Expression of Receptor Activator of Nuclear Factor-κB Ligand in Periodontal Ligament Fibroblasts", Molecules and Cells, 31(6), pp.573~578 (2011), 한국분자세포생물학회
- J. P. Steinbach, "Inhibition of Epidermal Growth Factor Receptor Signaling Protects Human Malignant Glioma Cells from Hypoxia-Induced Cell Death", Cancer Research, 64(5), pp.1575~1578 (2004), American Association for Cancer Research (AACR)[DOI]
- Shannon Elise Goldsmith Hamrick, "A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection", Neuroscience Letters, 379(2), pp.96~100 (2005), Elsevier BV[DOI]
- Yang-SookChun, "Oxygen-Dependent and -Independent Regulation of HIF-1alpha", Journal of Korean Medical Science, 17(5), pp.581~588 (2002), 대한의학회
- Yang-Sook CHUN, "A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1α gene", Biochemical Journal, 362(1), pp.71~79 (2002), Portland Press Ltd.[DOI]
- Hsieh-Hsing Lee, "Hypoxia Enhances Chondrogenesis and Prevents Terminal Differentiation through PI3K", Akt, Scientific Reports, pp.2013, 3[DOI]
- M. Clauss, "The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities: IMPLICATIONS FOR A FUNCTIONAL ROLE OF PLACENTA GROWTH FACTOR IN MONOCYTE ACTIVATION AND CHEMOTAXIS", Journal of Biological Chemistry, 271(30), pp.17629~17634 (1996), American Society for Biochemistry & Molecular Biology (ASBMB)[DOI]
- HJ Knowles, "Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte–osteoclast differentiation via induction of VEGF", The Journal of Pathology, 215(1), pp.56~66 (2008), Wiley-Blackwell[DOI]
- Tae-Geon Kwon, "Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression", Journal of Cellular Biochemistry, 112(12), pp.3582~3593 (2011), Wiley-Blackwell[DOI]
- S.-H. Lee, "Runx2 Protein Stabilizes Hypoxia-inducible Factor-1 through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes", Journal of Biological Chemistry, 287(18), pp.14760~14771 (2012), American Society for Biochemistry & Molecular Biology (ASBMB)[DOI]
- Deckers MM, "Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation", Endocrinology, 141, pp.1667~1674 (2000)
- 백경화, "Hypoxia Inducible Factor-1α Directly Induces the Expression of Receptor Activator of Nuclear Factor-κB Ligand in MLO-Y4 Osteocytes", International Journal of Oral Biology, 40(1), pp.19~25 (2015), 대한구강생물학회[DOI]
- Hayato Fukuoka, "Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells", Biochemical and Biophysical Research Communications, 328(4), pp.885~894 (2005), Elsevier BV[DOI]
- Maria J Martínez-Calatrava, "RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis", Arthritis Research & Therapy, 14(3), pp.R149~ (2012), Springer Nature[DOI]